Brainsway Ltd (BWAY)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $406.96M
Last updated: Nov 17, 2026 at 10:59 AM ET
Brainsway Ltd (BWAY) Financials: Revenue, Profit and Cash Flow
Brainsway reported revenue of $52.23M for the fiscal year ended Dec 31, 2025, up 27.3% from the year before. That year, net income was $7.63M with a net margin of 14.6%, operating cash flow was $18.16M and free cash flow was $16.40M. The quarter ended Sep 30, 2026 had revenue of $18.00M and net income of $2.20M.
Revenue and Margins
The operating margin was 8.3% in the fiscal year ended Dec 2025, the highest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $11.52M, a compound annual rate of 18.3%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $52.23M | +27.3% | 75.4% | 8.3% | 14.6% |
| Dec 2024 | $41.02M | +29.0% | 74.6% | 3.4% | 7.1% |
| Dec 2023 | $31.79M | +17.0% | 73.9% | -15.6% | -13.2% |
| Dec 2022 | $27.18M | -8.4% | 73.8% | -46.7% | -49.1% |
| Dec 2021 | $29.66M | +34.5% | 77.7% | -16.9% | -21.8% |
| Dec 2020 | $22.06M | -4.5% | 77.1% | -21.9% | -24.4% |
| Dec 2019 | $23.10M | +40.9% | 77.8% | -36.7% | -44.7% |
| Dec 2018 | $16.40M | +47.1% | 78.1% | -31.2% | -39.5% |
| Dec 2017 | $11.14M | -3.3% | 76.7% | -59.3% | -63.3% |
| Dec 2016 | $11.52M | N/A | 78.9% | -18.0% | -20.8% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 161.3% from the year before. In the quarter ended Sep 2026, net income rose 40.1% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $52.23M | $41.02M | $31.79M | $27.18M | $29.66M | $22.06M | $23.10M | $16.40M | $11.14M | $11.52M |
| Cost of revenue | $12.84M | $10.44M | $8.31M | $7.13M | $6.60M | $5.06M | $5.13M | $3.59M | $2.60M | $2.43M |
| Gross profit | $39.39M | $30.58M | $23.48M | $20.05M | $23.06M | $17.00M | $17.97M | $12.81M | $8.55M | $9.10M |
| Research and development | $9.60M | $7.19M | $6.67M | $7.68M | $6.39M | $5.82M | $7.88M | $6.16M | $5.34M | $3.79M |
| Operating income | $4.32M | $1.39M | -$4.96M | -$12.68M | -$5.00M | -$4.83M | -$8.48M | -$5.11M | -$6.61M | -$2.07M |
| Net income | $7.63M | $2.92M | -$4.20M | -$13.35M | -$6.46M | -$5.38M | -$10.33M | -$6.48M | -$7.05M | -$2.40M |
| EBITDA | $11.46M | $5.36M | -$2.56M | -$11.45M | -$4.67M | -$2.15M | -$7.90M | -$4.40M | -$5.56M | -$1.34M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $18.00M | $17.40M | $15.53M | $14.54M | $13.51M | $12.63M | $11.54M | $11.41M | $10.50M | $10.01M | $9.10M | $9.03M |
| Gross profit | $14.02M | $12.99M | $11.68M | $11.12M | $10.16M | $9.50M | $8.61M | $8.51M | $7.72M | $7.54M | $6.81M | $6.74M |
| Operating income | $2.57M | $2.43M | $2.00M | $1.92M | $1.25M | $578.00K | $576.00K | $431.00K | $281.00K | $586.00K | $93.00K | $10.10M |
| Net income | $2.20M | $2.76M | $2.29M | $2.93M | $1.57M | $2.03M | $1.11M | $1.55M | $662.00K | $600.00K | $111.00K | $127.00K |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of $1.07M by $66.63M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $112.92M | $94.32M | $62.97M | $64.48M | $75.73M | $34.01M | $38.74M | $23.60M | $27.03M | $19.96M |
| Current assets | $84.89M | $79.67M | $55.47M | $58.09M | $65.45M | $24.30M | $28.83M | $13.48M | $17.89M | $13.11M |
| Cash and equivalents | $67.70M | $69.34M | $10.52M | $47.58M | $16.92M | $16.96M | $21.67M | $8.97M | $14.51M | $9.17M |
| Total liabilities | $39.70M | $32.00M | $21.39M | $19.08M | $18.41M | $14.38M | $14.52M | $16.65M | $14.31M | $9.68M |
| Short-term debt | $1.07M | $824.00K | $232.00K | $234.00K | $500.00K | $429.00K | $414.00K | $750.00K | $1.63M | $810.00K |
| Long-term debt | N/A | N/A | N/A | N/A | N/A | N/A | $0 | $2.08M | $2.73M | $0 |
| Shareholder equity | $73.22M | $62.31M | $41.58M | $45.40M | $57.33M | $19.63M | $24.22M | $6.95M | $12.72M | $10.29M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $125.89M | $121.97M | $117.00M | $112.92M | $113.06M | $111.56M | $100.20M | $93.99M | $72.10M | $65.63M | $65.14M | $62.97M |
| Total liabilities | $43.66M | $42.79M | $41.20M | $39.70M | $43.00M | $43.43M | $36.45M | $31.67M | $28.07M | $22.65M | $23.15M | $21.39M |
| Cash and equivalents | $30.05M | $62.36M | $58.64M | $67.70M | $70.46M | $67.91M | $71.60M | $69.34M | $48.13M | $48.14M | $12.38M | $10.52M |
| Shareholder equity | $82.24M | $79.19M | $75.80M | $73.22M | $70.06M | $68.13M | $63.75M | $62.31M | $44.03M | $42.98M | $42.00M | $41.58M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 90.3% of operating cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $18.16M | $10.30M | $1.28M | -$9.76M | $884.00K | -$1.44M | -$7.24M | -$3.77M | -$3.47M | -$2.40M |
| Capital expenditures | $1.76M | $3.79M | $2.39M | $9.72M | $2.24M | $2.47M | $3.31M | $1.97M | $985.00K | $408.00K |
| Free cash flow | $16.40M | $6.50M | -$1.10M | -$19.48M | -$1.35M | -$3.91M | -$10.55M | -$5.75M | -$4.45M | -$2.81M |
| Investing cash flow | -$17.63M | $30.31M | -$37.41M | $42.17M | -$42.22M | -$2.46M | -$2.45M | -$1.14M | -$2.45M | -$393.00K |
| Financing cash flow | -$2.23M | $18.26M | -$1.03M | -$1.55M | $41.52M | -$1.03M | $22.47M | -$265.00K | $11.11M | $570.00K |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $6.16M | $6.36M | $1.17M | -$759.00K | $1.39M | $12.38M | $5.01M | $3.43M | $2.28M | $1.35M | $3.18M | $2.47M |
| Capital expenditures | $390.06K | $897.55K | $769.00K | $1.27M | $800.00K | $1.17M | $1.04M | $851.00K | $1.30M | $847.00K | $724.00K | $442.00K |
| Free cash flow | $5.77M | $5.46M | $402.00K | -$2.03M | $586.00K | $11.22M | $3.97M | $2.58M | $978.00K | $501.00K | $2.45M | $2.03M |
Frequently Asked Questions About BWAY
What is Brainsway's annual revenue?
Brainsway reported revenue of $52.23M for the fiscal year ended Dec 31, 2025.
How fast is Brainsway's revenue growing?
Revenue was up 27.3% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 24.3%.
Is Brainsway profitable?
Yes. Brainsway reported net income of $7.63M for the fiscal year ended Dec 31, 2025, with a net margin of 14.6%.
How much free cash flow does BWAY generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $18.16M minus capital expenditures of $1.76M produced free cash flow of $16.40M.
How much debt does Brainsway have?
The balance sheet dated Dec 31, 2025 reported short-term debt of $1.07M and cash and equivalents of $67.70M.
BWAY pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors